07:20 AM EDT, 03/24/2025 (MT Newswires) -- Knight Therapeutics ( KHTRF ) overnight Sunday said G252 Capital has disposed of 2.5 million of its shares at $6.30 each, and no longer holds over 10% of Knight's outstanding shares.
G2S2 now owns 7.54 million Knight shares, for a 7.6% stake.